|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.740 USD | -2.88% |
|
-3.30% | +1.35% |
| 06-22 | Evolus, Inc.(NasdaqGM:EOLS) added to S&P Pharmaceuticals Select Industry Index | CI |
| 05-11 | Evolus, Inc. Launches Estyme Injectable Hyaluronic Acid Gels Collection in Europe | CI |
| Market Cap | 444M 390M 359M 334M 630M 42.2B 643M 4.31B 1.67B 20.71B 1.67B 1.63B 72.09B | P/E 2026 * |
-13.6x | P/E 2027 * | -46x |
|---|---|---|---|---|---|
| Enterprise Value | 571M 501M 461M 430M 811M 54.27B 827M 5.55B 2.15B 26.64B 2.14B 2.1B 92.72B | EV / Sales 2026 * |
1.73x | EV / Sales 2027 * | 1.49x |
| Free-Float |
83.36% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Evolus, Inc.
| 1 day | -2.88% | ||
| 1 week | -3.30% | ||
| Current month | -2.88% | ||
| 1 month | +3.37% | ||
| 3 months | +56.38% | ||
| 6 months | +1.35% | ||
| Current year | +1.35% |
| 1 week | 6.7 |  | 7.32 |
| 1 month | 5.95 | | 7.32 |
| Current year | 3.86 | | 7.32 |
| 1 year | 3.86 | | 10.2 |
| 3 years | 3.86 | | 17.82 |
| 5 years | 3.86 | | 17.82 |
| 10 years | 2.85 | | 39.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Moatazedi
CEO | Chief Executive Officer | 48 | 05/05/2018 |
Tatjana Mitchell
DFI | Director of Finance/CFO | 48 | 07/09/2025 |
Jon Yerbury
COO | Chief Operating Officer | - | 31/08/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Vikram Malik
CHM | Chairman | 63 | 31/12/2017 |
David Gill
BRD | Director/Board Member | 71 | 11/02/2018 |
David Moatazedi
BRD | Director/Board Member | 48 | 05/05/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 03-19 | Sell | Chief Technology Officer | 3,119 | 0.0048% | ||
| 03-19 | Sell | Chief Executive Officer | 13,669 | 0.0211% | ||
| 03-15 | Fiscal year | Chief Executive Officer | 251,698 | 0.3891% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.88% | -3.30% | -26.74% | -7.29% | 444M | |
| -0.64% | +6.67% | +53.59% | +154.11% | 1,063B | |
| +0.00% | +5.39% | +62.89% | +53.44% | 611B | |
| -0.23% | +6.88% | +32.14% | +86.34% | 444B | |
| +1.61% | -0.96% | +26.12% | +20.22% | 324B | |
| +1.79% | +0.18% | +35.59% | +35.80% | 285B | |
| +0.68% | -0.33% | +27.58% | +41.83% | 283B | |
| -0.40% | +2.34% | -26.83% | -40.32% | 219B | |
| -0.22% | +2.82% | +24.37% | +62.75% | 195B | |
| -0.29% | +0.65% | +12.75% | +63.45% | 156B | |
| Average | +0.11% | +2.21% | +22.15% | +47.03% | 358.11B | |
| Weighted average by Cap. | +0.47% | +4.16% | +38.25% | +77.27% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 330M 290M 267M 249M 469M 31.42B 479M 3.21B 1.24B 15.42B 1.24B 1.21B 53.67B | 388M 340M 313M 292M 551M 36.86B 562M 3.77B 1.46B 18.09B 1.46B 1.42B 62.96B |
| Net income | -33.31M -29.24M -26.92M -25.08M -47.3M -3.17B -48.27M -324M -125M -1.55B -125M -122M -5.41B | -10.56M -9.27M -8.54M -7.95M -15M -1B -15.3M -103M -39.78M -493M -39.66M -38.8M -1.72B |
| Net Debt | 127M 112M 103M 95.64M 180M 12.07B 184M 1.23B 478M 5.93B 477M 467M 20.63B | 132M 116M 107M 99.41M 187M 12.55B 191M 1.28B 497M 6.16B 496M 485M 21.44B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 01/07/26 | US$6.740 | -2.88% | 567,581 |
| 30/06/26 | US$6.940 | -2.66% | 596,307 |
| 29/06/26 | US$7.130 | 0.00% | 670,035 |
| 26/06/26 | US$7.130 | -0.28% | 2,075,327 |
| 25/06/26 | US$7.150 | +2.58% | 523,802 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- EOLS Stock
Select your edition
All financial news and data tailored to specific country editions
